ライフサイエンスコーパス: lab

1 n the corresponding gene from a common HIV-1 lab strain.

2 The best clusters comprised the 17 labs that obtained the expected HDVL values, including f

3 Of the 22 lab measurements evaluated, 15 (68%) showed significant

4 A lab based EWNS platform was developed to enable fine-tun

5 A lab still was used to perform pilot distillations accord

6 een between the commercially available and a lab-built sprayer.

7 lab-scale model of an aeration basin, and a lab-scale model of converging sewer pipes.

8 rganic waste via chain elongation, in both a lab-scale and a pilot-scale system.

9 This study demonstrates a lab scale feasibility to extract lycopene efficiently fr

10 We have developed a lab-on-a-chip (LOC) platform for electrochemical detecti

11 this technological gap, we have developed a lab-on-a-chip capable of mechanically inducing circular

12 The flow-based analyzer features a lab-in-syringe (LIS) setup with an integrated stirring s

13 nent and system validation at lab-scale in a lab environment).

14 nt cell numbers for feasibility studies in a lab setting and the cell populations often have reduced

15 h the potential drops in a flow channel in a lab-on-chip device that accommodates chemical reactions

16 nstants predicted experimental DBP loss in a lab-scale UV/H2O2 AOP well.

17 is based on studying single individuals in a lab.

18 ng efforts dedicated to the replacement of a lab-based detector by a cellphone with smart application

19 t work was dedicated to the development of a lab-on-chip device for water toxicity analysis and more

20 s the influence of the different stages of a lab-scale chocolate manufacturing process on the content

21 lloids (0.01-10 mum) in the supernatant of a lab-scale submerged anaerobic membrane bioreactor (SAnMB

22 chnology can also be easily transferred to a lab-on-a-chip platform for use in resource limited setti

23 hree types of wastewater systems: toilets, a lab-scale model of an aeration basin, and a lab-scale mo

24 from a synchrotron light source to utilise a lab-based microfocus X-ray source and flat panel detecto

25 d perivascular fat was demonstrated, where a lab-built 500 Hz optical parametric oscillator outputtin

26 ested for ADCC against cells infected with a lab-adapted HIV-1 isolate (HIV-1NL4-3), a primary HIV-1

27 A biosensor chip was then integrated with a lab-built low-cost miniaturized printed circuit board (P

28 ic the sample preparation procedure within a lab-on-a-chip device or cartridge, but these systems req

29 gradients of dissolved oxygen (DO) within a lab-on-a-chip platform.

30 y of software packages originate in academic labs, persistence of the software is compromised when de

31 llenges often lead to inconsistencies across labs and model organisms.

32 data reproducibility, confirm results across labs, and discover new collective knowledge by data reus

33 nce costs and easy sharing of strains across labs, one key appeal is the possibility to monitor singl

34 al samples, for which transferability across labs was established and which was further benchmarked u

35 The model formulas were analysed after lab-scale high-temperature short-time heating at pH 6.8.

36 The platform will allow lab testing to be performed in remote areas, and open up

37 BioContainers allows labs of all sizes to easily install bioinformatics softw

38 nd accurate quantitation of viral load among labs requires the use of international standards.

39 m in enhancing the performance of analytical lab-on-a-chip (LOC) devices.

40 position modeling (FDM) in a (bio)analytical/lab-on-a-chip research laboratory is described.

41 n water harvesting, biochemical analysis and lab-on-chip devices.

42 targeted drug delivery, bioengineering, and lab-on-a-chip devices.

43 ization of on-chip optical communication and lab-on-a-chip devices.

44 or low-cost, point-of-care (POC) devices and lab-on-a-chip (LOC) applications.

45 ine ecosystems worldwide; however, field and lab data have demonstrated it to be limited by iron, pho

46 s experimental approaches, both in field and lab, to identify a potential biological control species

47 Here we combine mathematical modelling and lab experimentation to investigate the predation of an i

48 High-throughput screening and lab-scale optimization were combined to develop the cata

49 history, presenting signs and symptoms, and lab values.

50 sktop, making it a scalable solution for any lab.

51 alysis of multi-omic microbiome datasets are lab-specific and often result in sub-optimal data usage.

52 rkflows need to follow the same practices as lab projects and notebooks, with organized data, documen

53 nced materials and sensing platforms such as lab-on-chip, lab-on-CD, lab-on-paper etc.

54 m offline and online measurements as well as lab and field studies of the SSA particle-mixing state.

55 sition and non-sleep disturbances as well as lab tests in Chinese fatal familial insomnia (FFI) subje

56 l fully-automated magnetic stirring-assisted lab-in-syringe analytical procedure has been developed f

57 e oil during its production was evaluated at lab-scale with an Abencor system.

58 Incineration tests were performed at lab-scale using a specific tubular furnace modified in o

59 being the component and system validation at lab-scale in a lab environment).

60 being the component and system validation at lab-scale in a relevant environment) and full oxy-fuel c

61 design in which students conduct research at labs located at geographically-distributed institutions

62 that have recently been developed in the Bae lab and how they may aid in the study of tumor transport

63 cue-reactivity task (day 7; n=81) and a bar lab paradigm (day 8).

64 and the number of drinks consumed in the bar lab.

65 ve to placebo, reduced VS activation and bar-lab drinking only among carriers of the DAT1 9-repeat al

66 A closed droplet based lab-on-a-chip (LOC) device has been developed for the di

67 ors with microfluidic- and nanofluidic-based lab-on-chip (LOC) devices for point-of-care (POC) diagno

68 more importantly, AuNPs-embedded paper-based lab-in-a-syringe (LIS) device is developed as a sensing

69 ers are never taught the equivalent of basic lab skills for research computing.

70 not only to be a facile synthesis with basic lab facility but also to have promising potential for lo

71 he cells are relevant and comparable between labs, and outline why this process is essential before t

72 ibility, this has not been evaluated between labs.

73 proaches that are difficult to share between labs.

74 r-precision fabrication to molecular biology labs, offering myriads of potential applications in the

75 handling and fluidic manipulation offered by lab-on-a-chip systems promises to yield powerful tools f

76 omparable to the commonly used C6 peptide by lab-based ELISA.

77 ng platforms such as lab-on-chip, lab-on-CD, lab-on-paper etc.

78 sts, which are performed only in centralized labs by experienced clinical staff using time-consuming

79 crocrystalline powder synthesis in chemistry labs, towards film deposition and processing in a cleanr

80 s and sensing platforms such as lab-on-chip, lab-on-CD, lab-on-paper etc.

81 mu-opioid receptor antagonists in a clinical lab setting.

82 V. of 10%) with those obtained in a clinical lab.

83 certainty and accuracy in 22 common clinical lab tests between one company offering blood tests obtai

84 ansformation of almost all of these clinical lab tests into POC tests that use a PGM.

85 ent with hand counting by a trained clinical lab scientist, where our instrument demonstrated an appr

86 hVISA is not routinely detected in clinical labs.

87 d lies outside the capacity of most clinical labs, necessitating reference laboratory testing and the

88 disease organizations, registries, clinical labs, biomedical resources, and clinical software tools

89 ily engineer non-pathogenic Escherichia coli lab strains to produce geOMVs displaying the glycan of t

90 er a GPLv3 license at www.github.com/COMBINE-lab/quark.

91 ll length scales, the development of complex lab-on-chip (LOC) systems is in the focus of many curren

92 re is high throughput, uses fewer consumable lab supplies, and provides excellent sensitivity with an

93 ablished without the need for time-consuming lab processes.

94 ter genes of interest, thus, reducing costly lab studies.

95 rscores the therapeutic potential of current lab-made hepatocytes, but also highlights deficiencies a

96 o define the therapeutic efficacy of current lab-made hepatocytes, we compare them to primary human h

97 some popular dishes prepared in a dedicated lab-kitchen: spaghetti alle vongole, pomodori al riso, g

98 ption and dissipation in electronic devices, lab-on-a-chip platforms and energy harvest/conversion sy

99 y even across screens performed by different labs using different libraries and reagents.

100 e and contrast recent studies from different labs that address these two important questions.

101 e expression datasets generated in different labs.

102 ifferences in annotation styles of different labs.

103 h resource, the use of autonomous disposable lab-on-a-chip (LOC) devices-conceived as only accessorie

104 es a novel handheld analyzer with disposable lab-on-a-chip technology for the electrical detection of

105 Even the most up-to-date dry lab cannot clinch this validation without a seasoned wet

106 mbination of flow analysis techniques, i.e., lab-on-valve (LOV) and multisyringe flow injection analy

107 resis instruments as well as electrophoretic lab-on-chip devices, while maintaining a performance in

108 nd 12 (100%) patients had treatment-emergent lab abnormalities.

109 of neuroscience laboratories, and it enables labs that are already doing in vivo patch clamping to sc

110 n this work, we present a photonic enzymatic lab-on-a-chip reactor based on cross-linked enzyme cryst

111 ich are typically slow and require expensive lab-based equipment.

112 intensity repeatability is compared for five lab-built sprayers using pork liver sections.

113 Following lab validation, we performed a human validation by colle

114 harmonic generation (HHG) sources allow for lab scale applications such as cancer cell classificatio

115 nanofluidic systems with logic circuits for lab-on-a-chip applications.

116 The system has been developed for lab-scale transfer and proved to be scalable for industr

117 nal processing, sensing and increasingly for lab-on-a-chip applications.

118 s have emerged that hold great potential for lab-on-chip applications, biointegration, low-cost sensi

119 ces with detection, sample, and reagents for lab-on-a-chip applications.

120 characterization of a multiplexed label-free lab-on-a-chip biosensor using silicon nitride (SiN) micr

121 d Firmicutes were consistently enriched from lab electrochemical systems on delta-MnO2 and amorphous

122 irected vaccines focus on glycoproteins from lab-adapted strains, which may poorly reflect primary vi

123 d into workflow execution sites ranging from lab workstations to the cloud.

124 The results from lab-scale methanogenic reactors showed that this step ac

125 ch possesses the potential transferring from lab scale to industrial production.

126 -physiological conditions that can vary from lab to lab.

127 ransversa has a split cluster with 10 genes (lab, pb, Hox3, Dfd, Scr, Lox5, Antp, Lox4, Post2, and Po

128 code is available on www.github.com/hemberg-lab/MPRAnator/ under the MIT license.

129 We further find initial evidence for home-lab links: common noun "copresence" (i.e., whether words

130 , C57/BL6 mice were immunized with the Hooke lab MOG kit, sacrificed at the peak of the disease and t

131 Recent advances in lab-on-a-chip techniques have allowed single-cell captur

132 e mechanisms using artificial stimuli and in lab experiments, less work has addressed camouflage in t

133 ld promise for radically new applications in lab-on-a-chip and microfluidic technology, diagnostics a

134 lasmonic tweezers for further development in lab-on-a-chip devices.

135 Current generation in lab-scale electrochemical reactors did not oscillate, bu

136 larity as a means of fluidic manipulation in lab-on-a-chip systems can potentially reduce the complex

137 lectrical manipulation of microstructures in lab-on-a-chip devices.

138 h specific BAM degradation rates obtained in lab conditions using either freshly grown cells or starv

139 nd integration of complex assay protocols in lab-on-a-disc systems.

140 Studies in lab animal species have established that conjugation of

141 e plethora of different datasets acquired in labs around the world.

142 % of bacterial species cannot be cultured in labs.

143 t can be isolated, cultured and sequenced in labs.

144 Here, we demonstrate a low-cost (<$2 in-lab), higher-throughput "pinwheel assay" platform that r

145 mercially available, systems constructed 'in-lab' provide researchers with a flexible, versatile, and

146 or 6-hour snoring sound recordings during in-lab full-night polysomnography, drug-induced sleep endos

147 We use a new dataset, which includes in-lab comprehension and home measures from the same infant

148 on the web with few ways to link them to in-lab datasets.

149 ed to in home recordings) correlated with in-lab comprehension.

150 d using various diagnostic devices including lab based equipment and biosensors.

151 r few experiments generated by an individual lab to the vast amount of relevant data freely available

152 es provide a convenient means for individual labs to generate customized CRISPR libraries of variable

153 ollectively generated by multiple individual labs.

154 tion times, and subjects markedly influenced lab results.

155 cation (DE) using micro sequential injection lab-on-valve (muSI-LOV) system is developed.

156 The current trend is toward fully integrated lab-on-chip platforms with smartphone readouts, enabling

157 Fully-integrated lab-on-chip sample preparation overcomes technical barri

158 This work describes a new type of integrated lab-on-a-membrane foldable device suitable for on-site d

159 ble point-of-care diagnostics by integrating lab-on-a-chip technology and electrochemical analysis.

160 ors have capability of being integrated into lab-on-a-chip (LOC), microfluidics, and micro total anal

161 en a few attempts to incorporate SP-PCR into lab-on-a-chip (LOC) devices.

162 We introduced TDB into lab rats, which do not host TDB, and measured host perfo

163 s spectrometry studies have shown high intra-lab reproducibility, this has not been evaluated between

164 s muscle mutants currently performed in many labs; the clusters may provide new insights and drive ne

165 Miniaturized lab-on-a-chip systems offer properties - e.g. low sample

166 d an ultra-low-cost, rapid, and miniaturized lab-on-a-chip (LOC) platform.

167 In this study a mobile lab was used to repeatedly visit a large number of locat

168 Multiple labs have reported that mammalian ovaries contain oogoni

169 ble quantitative proteomics data by multiple labs is achievable, and broadly serves to increase confi

170 al "pitfalls." Results generated in multiple labs are immune to these "pitfalls," suggesting that per

171 My lab examines the biological mechanisms neurons use to fi

172 The research in my lab and others demonstrated that the regulated and rate-

173 When I started my lab at the University of British Columbia in the 1970s,

174 say I share the scientific questions that my lab has been excitedly pursuing since starting in August

175 ir efforts by reducing training time for new lab members and increasing experimental durations by han

176 We present a novel lab-on-a-chip (LOC) device for the simultaneous detectio

177 erlying Stokes flow and the accessibility of lab-on-chip technology.

178 of avian alarm calls using a combination of lab and field experiments with great tits (Parus major),

179 e metabolic and immunological development of lab mice.

180 ar from a rapid device, simple to use out of lab.

181 ly, this study demonstrates the potential of lab-based interdisciplinary graduate curriculum.

182 ical studies exemplifying different types of lab-made hepatocytes that can potentially be used in aut

183 ogies that will make commercial upscaling of lab-on-chip products financially viable.

184 nt examples, showing a staggering variety of lab-on-a-chip systems for biosensing applications, are p

185 A few critical elements in the design of labs, research buildings, or campus can make interaction

186 ntific community by storm, with thousands of labs using it for applications from biomedicine to agric

187 tion of these as portable tools in an out-of-lab setting.

188 on of small molecule biomarkers in an out-of-lab setting.

189 n and purification of liposomes which offers lab-on-chip scale production.

190 es higher, respectively, than those based on lab measurements.

191 These predictions are often based on lab-derived phenomenological relationships between tempe

192 ntly developed submersible analyzer based on lab-on-chip (LOC) technology.

193 Microfluidics or lab-on-a-chip technology offer clear advantages over con

194 Viral infections typically used in other lab animals to deliver gene editing constructs have been

195 xtile fibers (composites), whereas the other lab-prepared textiles contain Ag particles on the respec

196 Our lab has developed a Bipartile Alu Retrotransposition (BA

197 Our lab has previously shown histone deacetylases are modula

198 Our lab previously developed a perfusion technique based on

199 novel variants previously identified by our lab in the PALB2 gene in HEK239 cells, resulting in isog

200 lin) and CBLG (cationic BLG developed by our lab) were evaluated as potential nutraceutical/drug carr

201 e basis of previous methods disclosed by our lab, we sought to develop a predictive model for site se

202 Here we provide a summary of data from our lab and others that demonstrate the ability of hair foll

203 Previous work from our lab has shown that a small transmembrane protein called

204 ing a calibration standard fabricated in our lab to test our probes, we obtain simultaneous topograph

205 with a focus on strategies developed in our lab, to specifically localize complement inhibition to s

206 nitude higher than typically obtained in our lab.

207 Together with novel data from our labs, we find that the optimal on-target efficiency pred

208 ng various data elements, such as outpatient lab workup, pathology, radiology, current treatments, mo

209 ctures induced by Beau-R with the pathogenic lab strain M41 to determine whether membrane rearrangeme

210 idics leads to the highly promising photonic lab-on-a-chip analytical systems (PhLoCs).

211 re, we hereby report a microfluidic platform lab-on-a-disc (LOAD) to provide a sample-to-answer solut

212 e for the development of simple and portable lab-on-a-chip systems.

213 tion fitting current field data and previous lab data suggests that, in the context of recent studies

214 are often manipulated by several protocols, labs, or scientists in the process of sequencing.

215 hs (>300 cycles) of operation of a prototype lab-scale CANDO+P sequencing batch reactor treating synt

216 l multi-electrode polysilicon nanogap (PSNG) lab-on-chip is designed in this study, facilitates multi

217 cs technology to develop a multiplexed rapid lab-on-a-chip point of care (POC) assay for the serologi

218 ce of a substrate is essential for realizing lab-on-chip technologies.

219 Recipient lab rats were fed increasing concentrations of tannic ac

220 classroom, diagnostic centres, and research labs.

221 CCD cameras are ubiquitous in research labs, industry, and hospitals for a huge variety of appl

222 e conventional methods used in most research labs currently.

223 uting resources available with most research labs.

224 The extra noise mimics routine lab experiments more closely, ensuring any conclusions a

225 orm multistep chemical processes on a single lab-on-a-chip device.

226 run on commonly available machines in small labs.

227 n-field findings and discrepancies with some lab-based findings, with important implications for esti

228 n be tailored to broad applications spanning lab-on-a-chip device engineering to analysis of bioelect

229 ce metals determined in the ultraclean SWAMP lab using ICP-QMS.

230 d patterns, controlled drug release systems, lab-on-a-chip devices, and biosensors.

231 The lab-measured reproductive skew in the spores of chimeras

232 The lab-scale tests showed the power density of IT-GAC and C

233 erences in water flow velocities between the lab and the field.

234 ormed nanometer-sized by-products during the lab-scale synthesis of the carbon material.

235 nd with the aim to save time and energy, the lab-scale knowledge on SFME was exploited for the develo

236 e strategies that are transitioning from the lab to the clinic, and the assays and clinical assessmen

237 drug products have already stepped from the lab-bench to the market.

238 lush from the toilets or per minute from the lab-scale models, and the total volume of aerosols gener

239 3 weeks of chronic sleep restriction in the lab (i.e., 3 weekly cycles of 5 nights of 4 hours of sle

240 data quantitatively and predictively in the lab and clinic.

241 aracterize expression responses to Cu in the lab and field, we found evidence for a general stress re

242 approach in HIV-infected cells grown in the lab and in animal infections.

243 ch close mimicking of space radiation in the lab builds on the inherent ability of laser-plasma-accel

244 In the lab culture, after 550 generations, the strain exhibite

245 a prevalent mode in genome evolution in the lab culture.

246 imensional (3D) space, their behavior in the lab is almost exclusively scored in two dimensions, wher

247 acteristics in the field than it does in the lab, and early field phenotypic analyses of hypotheses c

248 enerous behavior is not only observed in the lab, but also expected by subjects.

249 rtificial tasks that, although useful in the lab, do not reflect the real world.

250 In the lab, the accuracy is 0.9% or better for all gas ratios u

251 For initial validation in the lab, we optimized and evaluated the performance of ironP

252 elicit high intensity awe experiences in the lab.

253 ntial therapeutics for focussed study in the lab.

254 atory tasks that manipulate curiosity in the lab.

255 nexpensive, convenient method for use in the lab.

256 n (LOQ), and the linear dynamic range of the lab-on-a-chip SERS (LoC-SERS) method for NTX detection i

257 ll materials used for the fabrication of the lab-on-chip platform were selected in order to obtain a

258 ferentially parallel or perpendicular to the lab-fixed relative velocity.

259 Using the lab strain NL4-3, we found that A5 (env/nef) is the most

260 signs are often fairly advanced, whereas the lab-on-a-chip aspect is still rather simplistic in many

261 ces for a clinical isolate compared with the lab strain.

262 The labs were grouped in four clusters by the statistical an

263 ring values reached the threshold before the labs in 45 of 102 instances (44%) and at 7 g/dL, noninva

264 fficult porting these methods outside of the labs that have developed them.

265 le-patient samples have to be sent in to the labs for analysis.

266 increased potential for real life out-of-the-lab applications.

267 scientists are facing having to close their labs.

268 the future visions in order to propel their "lab-to-market" realization.

269 These lab-made hepatocytes show promise in animal models of li

270 Two among these lab-prepared textiles represent materials in which Ag-NP

271 cy combs hold promise for transforming these lab-scale oscillators to chip-scale level.

272 Thirteen labs (46.3%) properly quantified all 18 positive samples

273 A previous publication from this lab explored the antitrypanosomal activities of novel de

274 Thus, this lab-based study for the first time unifies findings from

275 nocarcinoma sections are analyzed with three lab-built sprayers, and classification accuracy for aden

276 s using classical cell-based assays in three labs and a single molecule-based imaging method.

277 logical conditions that can vary from lab to lab.

278 collected from production sites and sent to labs.

279 er a timescale exceeding that of traditional lab experiments.

280 and user-friendly alternative to traditional lab-based assays.

281 enhanced degradation was investigated in two lab-scale sequencing batch reactors (SBRs), using bisphe

282 Tumors grown under lab conditions are developed much more quickly than natu

283 We used lab micro-colonies of honey bees and video analyses to t

284 g a wide palette of experiments from various labs.

285 tector allows the hyphenation with versatile lab-on-a chip (LOC) technology.

286 Here, we report results of a virtual lab experiment in which 94 subjects play up to 400 ten-r

287 Similar to a B virus lab strain, B virus clinical strains can effectively use

288 measured by the presence of a clinic visit, lab test, or ART initiation 6 to 18 months after initial

289 linch this validation without a seasoned wet lab.

290 In this study, we utilized wet lab migration experiments and quantitative histological

291 lds, utilizing various computational and wet-lab techniques, they often can produce only partial erro

292 Using the first 47 primer pools for wet-lab validation, we sequenced 25Kb at 99.7% completeness

293 uced LEL flexibility patterns known from wet-lab experiments in which the LEL delta-loop region showe

294 Validation of some predictions in wet-lab assays, together with re-evaluation of existing tran

295 ) that allows non-expert users including wet-lab scientists to comprehensively build, run and analyze

296 cription factor candidates together with wet-lab experiments validating computational models.

297 on, there is a high degree of agreement with lab instruments.

298 ivity of the immunoassays is comparable with lab-based immunoassays and at least equal or better than

299 imed at developing liver cell therapies with lab-made hepatocytes.

300 and analyzing NMR data is quite large, with labs relying on dozens, if not hundreds of software pack